The Use of Molecular Techniques to Distinguish BK Nephropathy From Acute Rejection: Close but not Quite
- PMID: 34288637
- DOI: 10.1097/TP.0000000000003885
The Use of Molecular Techniques to Distinguish BK Nephropathy From Acute Rejection: Close but not Quite
Conflict of interest statement
The author declares no conflicts of interest.
Comment on
-
A 2-fold Approach to Polyoma Virus (BK) Nephropathy in Kidney Transplants: Distinguishing Direct Virus Effects From Cognate T Cell-mediated Inflammation.Transplantation. 2021 Nov 1;105(11):2374-2384. doi: 10.1097/TP.0000000000003884. Transplantation. 2021. PMID: 34310102
References
-
- Purighalla R, Shapiro R, McCauley J, et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis. 1995;26:671–673.
-
- Muhsin SA, Wojciechowski D. BK virus in transplant recipients: current perspectives. Transpl Res Risk Manag. 2019;11:47–58.
-
- Halloran PF, Madill-Thomsen KS, Böhmig G A, et al. A two-fold approach to polyoma virus (BK) nephropathy in kidney transplants: distinguishing direct virus effects from cognate T-cell–mediated inflammation. Transplantation. Epub ahead of print. July 6, 2021. doi:10.1097/TP.0000000000003884 - DOI
-
- Halloran PF, Pereira AB, Chang J, et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am J Transplant. 2013;13:2865–2874.
-
- Halloran PF, Reeve J, Akalin E, et al. Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX Study. Am J Transplant. 2017;17:2851–2862.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
